Results of multivariate analysis for transplantation-related mortality, relapse, leukemia-free, and overall survival by transplantation conditioning regimen
| Outcome . | Hazard ratio (95% confidence interval) . | P . |
|---|---|---|
| Myeloablative conditioning regimen | ||
| Transplantation-related mortality | ||
| Double UCB vs single UCB | 0.81 (0.52-1.28) | .37 |
| Relapse* | ||
| Double UCB vs single UCB | 0.94 (0.51-1.73) | .84 |
| Treatment failure (inverse of LFS)† | ||
| Double UCB vs single UCB | 0.88 (0.61-1.26) | .48 |
| Overall mortality† | ||
| Double UCB vs single UCB | 0.88 (0.61-1.27) | .51 |
| Reduced-intensity conditioning regimen | ||
| Transplantation-related mortality | ||
| Double UCB vs single UCB | 1.49 (0.51-4.36) | .46 |
| Relapse* | ||
| Double UCB vs single UCB | 0.88 (0.47-1.63) | .67 |
| Treatment failure (inverse of LFS)† | ||
| Double UCB vs single UCB | 1.08 (0.64-1.82) | .78 |
| Overall mortality† | ||
| Double UCB vs single UCB | 1.01 (0.57-1.77) | .98 |
| Outcome . | Hazard ratio (95% confidence interval) . | P . |
|---|---|---|
| Myeloablative conditioning regimen | ||
| Transplantation-related mortality | ||
| Double UCB vs single UCB | 0.81 (0.52-1.28) | .37 |
| Relapse* | ||
| Double UCB vs single UCB | 0.94 (0.51-1.73) | .84 |
| Treatment failure (inverse of LFS)† | ||
| Double UCB vs single UCB | 0.88 (0.61-1.26) | .48 |
| Overall mortality† | ||
| Double UCB vs single UCB | 0.88 (0.61-1.27) | .51 |
| Reduced-intensity conditioning regimen | ||
| Transplantation-related mortality | ||
| Double UCB vs single UCB | 1.49 (0.51-4.36) | .46 |
| Relapse* | ||
| Double UCB vs single UCB | 0.88 (0.47-1.63) | .67 |
| Treatment failure (inverse of LFS)† | ||
| Double UCB vs single UCB | 1.08 (0.64-1.82) | .78 |
| Overall mortality† | ||
| Double UCB vs single UCB | 1.01 (0.57-1.77) | .98 |